daunorubicin has been researched along with ly335979 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castanys, S; Chávez Orellana, H; Estévez-Braun, A; Gamarro, F; Jiménez-Alonso, S; López, M; Muñoz Martinez, F; Pérez-Lomas, AL; Ravelo, AG | 1 |
| De Angelis, P; den Boer, M; Lehne, G; Rugstad, HE | 1 |
| den Boer, M; Lehne, G; Mørkrid, L; Rugstad, HE | 1 |
| Green, LJ; Marder, P; Slapak, CA | 1 |
| Aarons, L; Burgess, M; Callies, S; de Alwis, DP; Mehta, A | 1 |
| Baker, RJ; Burgess, M; Ethell, M; Ganeshaguru, K; Gerrard, G; Jones, DT; McCullough, H; Mehta, AB; Payne, E; Potter, M; Prentice, HG | 1 |
| Baer, MR; Duran, GE; Fielding, R; Lancet, JE; List, AF; Marcelletti, JF; Multani, PS; Sikic, BI | 1 |
| Bennett, JM; Cripe, LD; Ketterling, RP; Lazarus, HM; Litzow, MR; Luger, S; Paietta, EM; Rowe, JM; Tallman, MS; Uno, H | 1 |
4 trial(s) available for daunorubicin and ly335979
| Article | Year |
|---|---|
Population pharmacokinetic model for daunorubicin and daunorubicinol coadministered with zosuquidar.3HCl (LY335979).
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bile Canaliculi; Daunorubicin; Dibenzocycloheptenes; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Multiple; Humans; Models, Theoretical; Quinolines | 2004 |
Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine.
Topics: Abdominal Pain; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytarabine; Daunorubicin; Diarrhea; Dibenzocycloheptenes; Drug Resistance; Drug Screening Assays, Antitumor; Female; Flow Cytometry; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Nausea; Quinolines; Remission Induction | 2004 |
A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytarabine; Daunorubicin; Dibenzocycloheptenes; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Quinolines; Time Factors | 2009 |
Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Daunorubicin; Dibenzocycloheptenes; Female; Humans; Leukemia, Myeloid, Acute; Male; Multivariate Analysis; Placebos; Prognosis; Quinolines; Remission Induction; Survival Analysis; Treatment Outcome | 2010 |
4 other study(ies) available for daunorubicin and ly335979
| Article | Year |
|---|---|
Bis-pyranobenzoquinones as a new family of reversal agents of the multidrug resistance phenotype mediated by P-glycoprotein in mammalian cells and the protozoan parasite Leishmania.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzoquinones; Crystallography, X-Ray; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Leishmania tropica; Mice; Models, Molecular; Molecular Structure; NIH 3T3 Cells; Parasitic Sensitivity Tests; Phenotype; Stereoisomerism; Structure-Activity Relationship | 2008 |
Growth inhibition, cytokinesis failure and apoptosis of multidrug-resistant leukemia cells after treatment with P-glycoprotein inhibitory agents.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporins; Daunorubicin; Dibenzocycloheptenes; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Leukemia; Peptides, Cyclic; Phenotype; Quinolines; Tumor Cells, Cultured | 1999 |
Diverse effects of P-glycoprotein inhibitory agents on human leukemia cells expressing the multidrug resistance protein (MRP).
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Cyclosporins; Daunorubicin; Dibenzocycloheptenes; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescence; Humans; Leukemia, Myeloid; Peptides, Cyclic; Quinolines; Tumor Cells, Cultured | 2000 |
Modulation by LY335979 of P-glycoprotein function in multidrug-resistant cell lines and human natural killer cells.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Daunorubicin; Dibenzocycloheptenes; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Multiple; Fluorescent Dyes; HL-60 Cells; Humans; Killer Cells, Natural; Quinolines; Rhodamine 123 | 2001 |